MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia

Understanding the underlying molecular mechanisms of defined cancers is crucial for effective personalized therapies. Translocations of the mixed-lineage leukemia (MLL) gene produce fusion proteins such as MLL-AF4 that disrupt epigenetic pathways and cause poor-prognosis leukemias. Here, we find tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Kerry, Jon, Godfrey, Laura, Repapi, Emmanouela, Tapia, Marta, Blackledge, Neil P., Ma, Helen, Ballabio, Erica, O’Byrne, Sorcha, Ponthan, Frida, Heidenreich, Olaf, Roy, Anindita, Roberts, Irene, Konopleva, Marina, Klose, Robert J., Geng, Huimin, Milne, Thomas A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cell Press 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5263239/
https://www.ncbi.nlm.nih.gov/pubmed/28076791
http://dx.doi.org/10.1016/j.celrep.2016.12.054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5263239/
https://www.ncbi.nlm.nih.gov/pubmed/28076791
http://dx.doi.org/10.1016/j.celrep.2016.12.054

Ejemplares similares